The original GHRH analogue — studied since the 1980s for endogenous GH pathway research. 40+ published studies. 99%+ HPLC-verified purity. 3-lab independent COA on every batch.
Sermorelin is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH), consisting of the first 29 amino acids of the naturally occurring 44-amino-acid GHRH sequence. This fragment retains full biological activity at the pituitary GHRH receptor, making it one of the longest-studied compounds in growth hormone pathway research.
First characterized in the 1980s, sermorelin has accumulated 40+ published studies examining its role in stimulating endogenous growth hormone release via pituitary somatotroph cells, age-related GH decline models, and body composition research. Unlike exogenous HGH, sermorelin works through the body's natural feedback mechanisms.
Sermorelin is classified as a research-use-only compound at SMART MD Peptides. It is not FDA-approved for any therapeutic indication when sold as a research compound. All references below describe research contexts, not human clinical outcomes.
Sermorelin's primary mechanism of action is studied at the pituitary somatotroph cell level — binding to GHRH receptors to stimulate release of stored growth hormone through natural secretory pathways and pulsatile release patterns.
Published research examines sermorelin in models of somatopause — the age-related decline in growth hormone output. Studies explore whether GHRH receptor stimulation can restore more youthful GH pulsatility patterns in aging models.
Preclinical and clinical literature examines sermorelin's effects on lean mass, adipose tissue distribution, and metabolic rate — downstream effects of restored GH signaling in research models.
Sermorelin has been used as a diagnostic tool in research settings to assess pituitary GH reserve capacity. Its predictable receptor-mediated response makes it useful for evaluating somatotroph cell function.
Sermorelin is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH), consisting of the first 29 amino acids of the full 44-amino-acid GHRH sequence. It retains full biological activity and has been studied since the 1980s for its role in stimulating endogenous growth hormone release from the pituitary gland.
HGH (human growth hormone) is exogenous — it directly replaces growth hormone in the body. Sermorelin stimulates the pituitary to release its own stored GH through natural feedback mechanisms. This preserves pulsatile release patterns and endogenous regulation. Researchers study sermorelin as a more physiological approach to GH pathway modulation.
Sermorelin is a GHRH analogue — it works at the GHRH receptor on pituitary somatotroph cells. Ipamorelin is a growth hormone secretagogue (GHS) — it works at the ghrelin/GHS receptor. They use different pathways to stimulate GH release, which is why researchers often study them in combination for synergistic effects.
Research-grade Sermorelin with 3-lab COA verification is available at SMART MD Peptides in 5mg and 10mg formulations. Every batch is independently verified for purity (99%+) and publicly verifiable at smartmdpeptides.com/verify.
Lyophilized (unreconstituted) Sermorelin should be stored at -20°C, protected from light. Once reconstituted, store at 2-8°C and use within the timeframe specified on your lot-specific documentation.
Check the COA before you buy. Compare it against any other supplier's documentation.